Our Board Chapter is made up of four incredibly experienced individuals who come together and lead the way in ensuring not only TALi meets its objectives set out through strategy, but also that we meet the obligations set by you the shareholder. 
As a company, TALi is exceptionally lucky to have owned the support of its shareholders over many years. And we still strive to ensure we maintain this strength through our leaders at the top.

Meet our fearless Board.


Ms Sue Macleman | Non-Executive Chair 

Sue has more than 30 years experience as a pharmaceutical, biotechnology and medical technology executive with senior roles in corporate, medical, commercial and business development. Sue has served as CEO and Board Member of several ASX and NASDAQ listed companies in the sector.

Joined TALi's Board | 2018


Mr Jefferson Harcourt | Non-Executive Director

Jefferson has over 15 years of experience as a company director and founder of grey innovation, a cutting edge engineering and technology commercialisation company based in Melbourne, Australia. Jefferson has brought over one hundred products to market in the past fifteen year, and these devices are sold under leading brand names around the world.

Joined TALi Board | 2016


Dr David Brooks | Non-Executive Director

Dr Brooks has extensive experience in the health and biotechnology industries, as a rural clinician and as a consultant in the biotechnology sector since the late 1990's. David has since held a board position in a number of ASX listed companies, including as chair of RHS Ltd which was acquired by Perkin Elmer in 2018.

Joined TALi Board | 2020


David Williams | Non-Executive Director

David brings extensive international and domestic healthcare sector experience including 25 years with Cochlear Limited. David held a number of senior commercial and financial roles with the medical devices leader including president of Cochlear Americas (acting) and VP of global customer experience.

Joined TALi Board | 2021

Send an inquiry